AKT1 and inflammatory bowel disease: Many studies have provided evidence to support this point; for example, inhibition of AKT phosphorylation effectively alleviates inflammatory mastitis (Kan et al., 2019), inflammatory neurological disease (Huang et al., 2018), and inflammatory bowel disease (Chen et al., 2018).